Anthropic launches Claude Science with Court Pharma ahead of IPO – MedCity News
Anthropic deploys Claude Science, an AI workshop for pharmaceutical researchers. The bustling AI startup says this new product goes beyond ...
Read moreDetails
Tag: biopharma nl
FDA approves thyroid eye disease drug from Viridian, rival to blockbuster Amgen Med – MedCity News
A Viridian Therapeutics drug for thyroid eye disease now has FDA approvalmaking it just the second treatment for this inflammatory ...
Read moreDetails
EMA: the benefits of the inflammation drug Amgen and Vifor no longer outweigh the risks – MedCity News
Regulatory pressure mounts on Amgen's inflammatory disorder drug Tavneos at the European Medicines Agency (EMA) recommend revocation of product approval ...
Read moreDetails
New FDA deal keeps Gilead drug competitive with AstraZeneca and Daiichi in breast cancer treatment – MedCity News
The FDA has expanded approval of a targeted therapy from Gilead Sciences as a new first-line treatment for triple-negative breast ...
Read moreDetails
Things to Consider Before Taking Your Biotech Company Public – MedCity News
After a few gloomy years, biotech IPOs rebound in 2026. A new record for the sector most cash raised by ...
Read moreDetails
Former FDA officials: There is an opportunity to rebuild the agency – but not like before – MedCity News
The FDA's operational structure around centers, each governing a particular regulatory or scientific area, dates back more than 40 years. ...
Read moreDetails
Servier launches into muscular dystrophy, pays $1.5 billion for Edgewise Therapeutics assets – MedCity News
Servier is expanding its neurology focus to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers a ...
Read moreDetails
AstraZeneca and Daiichi drug approved as new first-line treatment for severe breast cancer – MedCity News
A Daiichi Sankyo and AstraZeneca drug is now available approved as first-line treatment for a type of breast cancer that ...
Read moreDetails
This TechBio startup just raised $2 billion without disclosing any details about its drugs – MedCity News
When a biotech startup reveals significant funding, the announcement typically includes information about a pipeline, or at least a lead ...
Read moreDetails
Four biotech IPOs raise $1.5 billion in April, biggest month in five years – MedCity News
The IPO window for biotech companies appears to be reopening. Last week ended with three biotech companies hitting the public ...
Read moreDetails
Trusted news coverage delivering accurate reporting, breaking headlines, and insightful analysis on global events, business, politics, and tech.